CAS: 442908-10-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Vipadenant REF: IN-DA0039VLCAS: 442908-10-3 | 98% | To inquire | Mon 18 Nov 24 |
 | Vipadenant REF: TM-T2373CAS: 442908-10-3 | 97.25% - 97.36% | 40.00 €~1,105.00 € | Mon 25 Nov 24 |
 | Vipadenant REF: 3D-SSA90810CAS: 442908-10-3 | Min. 95% | To inquire | Mon 30 Dec 24 |
Ref: IN-DA0039VL
| 1g | To inquire | ||
| 2mg | 51.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 106.00 € | ||
| 25mg | 150.00 € | ||
| 50mg | 252.00 € | ||
| 100mg | 567.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Monday 18 Nov 2024
Vipadenant
CAS:442908-10-3
Vipadenant (CEB-4520)(BIIB-014) is an adenosine A2a antagonist with Ki of 1.3 nM; less potent for …
Formula:
C16H15N7O
Purity:
97.25% - 97.36%
Color and Shape:
Solid
Molecular weight:
321.34
Ref: TM-T2373
| 1mg | 40.00 € | ||
| 2mg | 57.00 € | ||
| 5mg | 90.00 € | ||
| 10mg | 123.00 € | ||
| 25mg | 211.00 € | ||
| 50mg | 348.00 € | ||
| 100mg | 515.00 € | ||
| 500mg | 1,105.00 € | ||
| 1mL*10mM (DMSO) | 357.00 € |
Estimated delivery in United States, on Monday 25 Nov 2024
Vipadenant
CAS:442908-10-3
Vipadenant is a new drug that has been developed for the treatment of cancer. It …
Formula:
C16H15N7O
Purity:
Min. 95%
Molecular weight:
321.34 g/mol
Ref: 3D-SSA90810
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 30 Dec 2024
